Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001071005 | SCV001236286 | benign | Nemaline myopathy 2 | 2023-11-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002554612 | SCV003725565 | uncertain significance | Inborn genetic diseases | 2022-08-16 | criteria provided, single submitter | clinical testing | The c.7387A>T (p.M2463L) alteration is located in exon 54 (coding exon 52) of the NEB gene. This alteration results from a A to T substitution at nucleotide position 7387, causing the methionine (M) at amino acid position 2463 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001071005 | SCV001457010 | uncertain significance | Nemaline myopathy 2 | 2020-03-10 | no assertion criteria provided | clinical testing |